|本期目录/Table of Contents|

[1]柏冬 王瑞海 刘丽梅.近十年中药药代动力学新技术新方法概述[J].环球中医药,2016,9(07):891-895.[doi:10.3969/j.issn.1674-1749.2016.07.040]
 BAI Dong,WANG Rui-hai,LIU Li-mei..Review on new technologies and methods of pharmacokinetics of traditional Chinese medicines in recent 10 years[J].,2016,9(07):891-895.[doi:10.3969/j.issn.1674-1749.2016.07.040]
点击复制

近十年中药药代动力学新技术新方法概述()
     
分享到:

《环球中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
第9卷
期数:
2016年07期
页码:
891-895
栏目:
综述
出版日期:
2016-07-06

文章信息/Info

Title:
Review on new technologies and methods of pharmacokinetics of traditional Chinese medicines in recent 10 years
作者:
柏冬 王瑞海 刘丽梅
100700 北京,中国中医科学院中医基础理论研究所
Author(s):
BAI Dong WANG Rui-hai LIU Li-mei.
Institute of Basic Theory of TCM, China Academy of Chinese Medical Sciences, Beijing 100700, China
关键词:
中药药代动力学中药多组分整合药代动力学中药药代标记物代谢组学
Keywords:
Pharmacokinetics of traditional Chinese medicinesIntegral pharmacokinetic study of multiple componentsPharmacokinetic markers of traditional Chinese medicineMetabonomics
分类号:
R285.5
DOI:
10.3969/j.issn.1674-1749.2016.07.040
文献标志码:
A
摘要:
中药具有多成分、药效物质不确切的特征,长期以来中药药代动力学的研究存在许多困难。新的仪器、分析技术的出现,提高了中药体内成分分析的灵敏度,使得中药多成分药代研究成为可能。目前认为,在中药药代动力学研究中同时监测多个成分的药代动力学特征是十分有必要的,“中药多组分整合药代动力学研究”“中药药代标记物”“代谢组学”的研究思路较好地解决了这个问题。但目前的研究仍然存在许多争议,本文对近十年中药药代动力学的新技术与新方法进行综述,希望对中药药代动力学研究提供借鉴。
Abstract:
As the chemical compositions in traditional Chinese medicine is very complex and the effective components are not accurate,there are many difficulties in the study of traditional Chinese medicine. With the developments of new technologies and methods,a lot of achievements in the pharmacokinetics have been made at home. For example, the emergence of new instruments and analysis technology can improve the sensitivity of the analysis the composition of traditional Chinese medicine in vivo, and make it possible to study the composition of traditional Chinese medicine. It has been reached an agreement that monitoring multi-components' pharmacokinetics characteristic at the same time is very necessary. The research idea of “integral pharmacokinetic study of multiple components”, “pharmacokinetic markers of traditional Chinese medicine” and “metabonomics technology” can resolve this problems,but there are still of a lot of controversy in the present study. This paper organizes the related literature with pharmacokinetics of traditional Chinese medicine in recent 10 years. We hope it can provide reference for the study of pharmacokinetics of traditional Chinese medicines.

参考文献/References:

[1] 黎国富,赵浩如,杨劲. 中草药新药多成分药代动力学评价的研究进展[J]. 中国中药杂志,2011,36(05):644-649.
[2] 郝海平,郑超湳,王广基. 多组分、多靶点中药整体药代动力学研究的思考与探索[J]. 药学学报,2009,44(3):270-275.
[3] 叶祖光. 评美国FDA的《植物药研制指导原则》[J]. 医药世界,2004,6(11):31-33.
[4] 黄芳华. 从美国首个被批准植物药探讨中药药代动力学研究与评价策略[J]. 中国中药杂志,2010,35(7):932-935.
[5] 刘安昌,赵丽霞,邢杰,等. 液相色谱-串联质谱法测定大鼠血浆中脱水葛根素浓度及其药代动力学研究[J]. 中国天然药物,2013,11(5):566-571.
[6] Wang W,Hao HP,Wang GJ,et al. Simultaneous quantitation of dicaffeoylquinic acids in rat plasma after an intravenous administration of mailuoning injection using liquid chromatography-mass spectrometry[J]. J Chromatogr Sci,2009,47(3):216-222.
[7] 朱超,胡坪,梁琼麟,等. 脂组学及其研究进展[J]. 分析化学,2009,37(9):1390-1396.
[8] Zheng C,Hao H,Wang X,et al. Diagnostic fragment-ion-based extension strategy for rapid screening and identification of serial components of homologous families contained in traditional Chinese medicine prescription using high-resolution LC-ESI- IT-TOF/MS:Shengmai injection as an example[J]. J Mass Spectrom,2009,44(2):230-244.
[9] Hao H,Cui N,Wang G,et al. Global detection and identification of nontarget components from herbal preparations by liquid chromatography hybrid ion trap time-of-flight mass spectrometry and a strategy[J]. Anal Chem,2008,80(21):8187-8194.
[10] 李川,牛巍,孙艳,等. 利用液相色谱电解质效应结合脉冲梯度色谱技术提高药代筛选中生物样品液-质联用分析的速率[J]. 中国临床药理学与治疗学,2007,12(10):1181.
[11] Li L,Liang S,Du F,et al. Simultaneous quantification of multiple licorice flavonoids in rat plasma[J]. J Am Soc Mass Spectrom,2007,18(4):778-782.
[12] Zhao Y,Sun Y,Li C. Simultaneous determination of ginkgo flavonoids and terpenoids in plasma:ammonium formate in LC mobile phase enhancing electrospray ionization efficiency and capacity[J]. J Am Soc Mass Spectrom,2008,19(3):445-449.
[13] Cai F,Xu W,Wei H,et al. Simultaneous determination of active xanthone glycosides,timosaponins and alkaloids in rat plasma after oral administration of Zi-Shen Pill extract for the pharmacokinetic study by liquid chromatography-tandem mass spectrometry[J]. J Chromatogr B Analyt Technol Biomed Life Sci,2010,878(21):1845-1854.
[14] 刘彦娜,梁艳,王广基. 麦冬提取物中多种皂苷类成分的药代动力学[J]. 中国实验方剂学杂志,2014,14(9):137-142.
[15] 任浩,宿树兰,管汉亮,等. 复方柔肝中姜黄素类成分大鼠药代动力学特征[J]. 中成药,2014,36(3):498-503.
[16] 张英丰,董宇,朱晓新. 中药复方药代动力学研究的方法与思考[J]. 中国天然药物,2008,6(5):321-324.
[17] 赵保胜,刘洋,王晶娟,等. “暴露-反应-机制”三联研究模式学术思想及其中医药领域应用[J]. 世界中医药,2014,9(9):1234-1237.
[18] 李晓宇,郝海平,王广基,等. 三七总皂苷多效应成分整合药代动力学研究[J]. 中国天然药物,2008,6(5):377-381.
[19] 刘昌孝,王广基,钟大放,等. 我国近年来药物代谢与药物动力学研究[C]//中国药理学会药物代谢专业委员会.第九届全国药物和化学异物代谢学术会议论文集,武汉,2009.
[20] Liu H,Yang J,Du F,et al. Absorption and disposition of ginsenosides after oral administration of Panax notoginseng extract to rats[J]. Drug Metab Dispos,2009,37(12):2290-2298.
[21] Lu T,Yang J,Gao X,et al. Plasma and urinary tanshinol from Salvia miltiorrhiza(Danshen)can be used as pharmacokinetic markers for cardiotonic pills,a cardiovascular herbal medicine[J]. Drug Metab Dispos,2008,36(8):1578-1586.
[22] 高鹏飞,刘卫红,吴俊珠,等. 代谢组学在中医药研究中的应用进展[J]. 中国实验方剂学杂志,2011,17(21):284-288.
[23] 罗国安,梁琼麟,王义明,等. 中医药系统生物学发展及展望[J]. 中国天然药物,2009,7(4):242-248.
[24] 向铮,蔡小军,曾苏. 基于复杂网络与代谢组学的中药药代动力学研究思考与探索[J]. 药学学报,2012,47(5):558-564.
[25] Plumb RS,Stumpf CL,Granger JH,et al. Use of liquid chromatography/time-of-flight mass spectrometry and multivariate statistical analysis shows promise for the detection of drug metabolites in biological fluids[J]. Rapid Commun Mass Spectrom,2003,17(23):2632-2638.
[26] 王广基,郝海平,阿基业,等. 代谢组学在中药方剂整体药效作用及机制研究中的应用与展望[J]. 中国天然药物,2009,7(2):82-89.
[27] 王晓玲. 芍药苷的微生物转化研究[J]. 西南民族大学学报(自然科学版),2011,37(3):425-430.
[28] 宋丽,徐璐扬,张宁. 大鼠肠内微生物对甘草酸代谢的影响[J]. 上海中医药杂志,2008,42(9):70-72.

相似文献/References:

备注/Memo

备注/Memo:
基金项目: 国家重点基础研究发展计划(973计划)(2012CB518401)
作者简介: 柏冬(1983- ),博士,副研究员。研究方向:中药药效物质基础。E-mail:baidong2000@126.com
通讯作者: 刘丽梅(1965- ),女,本科,研究员。研究方向:中医方证基础研究。E-mail:liulimeihrb@163.com
更新日期/Last Update: 2016-07-06